Clinical Trial Update: An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 immunotherapy trial evaluating combination treatments in advanced cancer was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-03-22